# Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

> **NCT00145652** · PHASE3 · COMPLETED · sponsor: **Sundsvall Hospital** · enrollment: 66 (—)

## Conditions studied

- Anemia
- Multiple Myeloma
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Neo-Recormon and Venofer

## Key facts

- **NCT ID:** NCT00145652
- **Lead sponsor:** Sundsvall Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 66 (—)
- **Last updated:** 2007-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145652, "Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00145652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*